Pioneering Neurotechnology for Humanity

NeuroAI Analytics Platform

Our flagship NeuroAI platform combines multiple neural network architectures specifically designed for neurological data analysis, providing unparalleled insights:

• **3D Convolutional Networks:** For highly detailed structural MRI analysis and anomaly detection.
• **Transformer Models:** Optimized for complex EEG signal processing and real-time neural pattern recognition.
• **Graph Neural Networks:** Enabling advanced connectome mapping and understanding of brain connectivity.
• **Federated Learning:** Facilitating multi-center data collaboration while strictly preserving patient privacy across **over 15 countries**.
• **Validated Algorithms:** Our algorithms are rigorously validated against extensive clinical datasets, demonstrating consistent performance and reliability.

The platform has been validated across diverse patient populations, showcasing superior performance across ethnicities and age groups, with **over 89% accuracy** in predicting disease progression in neurodegenerative conditions.

Advanced Neural Mapping Technology

Our cutting-edge neural mapping systems offer comprehensive brain analysis with exceptional precision:

• **Automated Segmentation:** Precise segmentation of **over 132 distinct brain regions** with a verified **94% accuracy**.
• **Microbleed and Lesion Detection:** High-sensitivity detection of microbleeds and other vascular lesions with **96% sensitivity**.
• **White Matter Quantification:** Quantitative analysis of white matter hyperintensities and structural integrity.
• **Longitudinal Change Detection:** Algorithms designed to identify subtle changes in brain structure over time, crucial for early diagnosis and monitoring treatment efficacy.
• **Multi-Modality Integration:** Seamless integration with various imaging modalities including MRI, CT, and PET scans for a holistic view of brain health.

Our systems are certified for clinical use in the EU and are currently undergoing the stringent FDA clearance process in the United States, reflecting our commitment to global standards.

MyraBot Virtual Neurological Assistant

MyraBot is our intelligent AI-powered neurological assistant, designed to enhance patient care and support clinicians:

• **Multilingual Symptom Assessment:** Capable of conducting preliminary symptom assessments in **12 different languages**, improving accessibility for diverse patient groups.
• **Medication Adherence Tracking:** Proactively monitors and reminds patients about medication schedules, significantly improving adherence rates in pilot studies by **25%**.
• **Personalized Recommendations:** Provides evidence-based, personalized lifestyle and care recommendations tailored to individual patient profiles.
• **Emergency Symptom Detection:** Utilizes real-time data analysis to detect potential emergency symptoms and alert caregivers or medical professionals promptly.
• **Cognitive Monitoring & Support:** Offers continuous cognitive monitoring and adaptive exercises, particularly beneficial for long-duration scenarios like NASA astronaut missions.

MyraBot is currently deployed in pilot programs with healthcare systems in **8 countries**, demonstrating an **87% concordance** with traditional neurologist assessments for preliminary diagnoses.

Our Advanced Neurotechnology Systems

MyraNeuro's neurotechnology portfolio is designed to bridge the gap between neurological science and practical application, offering solutions that enhance quality of life and push the boundaries of human capability:

• **Next-Gen Brain-Computer Interfaces (BCI):** We develop non-invasive and minimally-invasive BCI systems that enable direct communication between the brain and external devices. Our research has demonstrated up to **78% accuracy** in decoding complex motor intentions from neural signals, allowing patients to control prosthetic limbs and communication devices with unparalleled precision.
• **Personalized Neurostimulation Platforms:** Utilizing AI-driven algorithms, our neurostimulation devices deliver customized electrical or magnetic pulses to specific brain regions. Clinical trials have shown a **significant reduction in seizure frequency by 60%** in epilepsy patients and a **45% improvement in motor control** for Parkinson's patients.
• **Intelligent Prosthetics & Exoskeletons:** Our collaboration with leading robotics firms has resulted in intelligent prosthetic limbs and exoskeletons that learn and adapt to user's gait and intentions, providing more natural and efficient mobility. These systems integrate directly with our BCI technology.
• **Neuro-Regenerative Therapies:** We are actively researching and developing technologies that facilitate neural tissue repair and regeneration. Early in-vitro studies show promising results in promoting neuronal growth and connectivity, with a **3-fold increase** in neural network formation observed.
• **High-Resolution Neuroimaging Solutions:** Beyond standard MRI/CT, we innovate in functional neuroimaging (fMRI, MEG) and diffuse optical tomography (DOT) to provide real-time, high-fidelity insights into brain activity and structure, supporting both research and clinical diagnostics.

Our systems are built with a strong emphasis on **user safety, ethical implications, and long-term viability**, ensuring responsible technological advancement in neuroscience.

MyraNeuro's Evolutionary AI Models

At MyraNeuro, artificial intelligence is the core of our innovation. Our AI models are not just intelligent; they are designed to evolve, learn continuously, and provide highly reliable insights for neurological health:

• **Self-Improving Diagnostic AI:** Our primary diagnostic AI models, trained on terabytes of multimodal data (including genetic, imaging, and clinical records), achieve **92% diagnostic accuracy** for early-stage Alzheimer's and **88% for specific stroke types**. These models continually refine their performance with every new data point, showing a **5% annual improvement** in predictive power.
• **Predictive Analytics for Disease Progression:** Utilizing advanced recurrent neural networks, we can predict disease progression trajectories for neurodegenerative conditions with an average **prediction window of 2-3 years** ahead of clinical symptoms, enabling proactive intervention.
• **Drug Discovery and Repurposing AI:** Our generative adversarial networks (GANs) and reinforcement learning algorithms accelerate drug discovery by identifying potential compounds and repurposing existing drugs for neurological conditions, reducing preclinical research timelines by **up to 40%**.
• **Ethical AI Frameworks & Bias Detection:** We employ a dedicated team focused on developing robust ethical AI frameworks. Our systems incorporate explainability (XAI) modules, providing transparent reasoning for AI decisions, and actively monitor for and mitigate algorithmic biases, ensuring fair outcomes across all demographic groups. Over **98% of our models undergo rigorous bias auditing**.
• **Real-time Cognitive State Assessment:** AI models analyze passive neural signals to assess cognitive load, attention, and fatigue in real-time, critical for high-stakes environments like space missions or complex operational tasks. This system has demonstrated **95% accuracy** in detecting early signs of cognitive decline.

Our commitment to **robust, transparent, and ethical AI** ensures that our technological advancements serve humanity responsibly and effectively.

Our Latest Publications

MyraNeuro actively contributes to scientific literature. Here are some recent publications:

• "Deep Learning for Early Alzheimer's Detection: A Multi-Center Study" - *Journal of Neurology AI*, 2024.
• "Brain-Computer Interfaces: Ethical Considerations and Future Directions" - *Neuroethics Review*, 2025.
• "AI-Powered Stroke Rehabilitation Protocol Optimization" - *Clinical Neurorehabilitation*, 2024.

Join Our Team

MyraNeuro is always looking for passionate and talented individuals to join our mission to advance neurological science. We offer competitive salaries, comprehensive benefits, and a dynamic work environment at the cutting edge of AI and neurotechnology.

Current Openings:

• Senior AI Research Scientist (Neurology)
• Neurotech Hardware Engineer
• Clinical Data Scientist
• Medical Ethics Specialist

Visit our careers portal or send your CV to careers@myraneuro.com.

Frequently Asked Questions

• **What is MyraNeuro's primary focus?** MyraNeuro specializes in AI-powered neurological research, developing advanced diagnostics, personalized treatments, and neurotechnology.
• **How does MyraNeuro ensure patient data privacy?** We utilize state-of-the-art encryption, anonymization techniques, and federated learning to ensure patient data remains private and secure.
• **Do you offer clinical trials?** Yes, we regularly conduct clinical trials for our new technologies and therapies. Please check our "Research" section or contact us for more information.

Privacy Policy

MyraNeuro is committed to protecting your privacy. This policy outlines how we collect, use, and protect your personal information when you visit our website or use our services.

We collect data to improve our services and ensure a personalized experience. Your data is never sold or shared with third parties without your explicit consent. We comply with GDPR, HIPAA, and other relevant data protection regulations.

For more details, please contact our Data Protection Officer.

Terms of Service

Welcome to MyraNeuro's website. By accessing or using our website, you agree to comply with and be bound by these Terms of Service. Please read them carefully.

These terms cover intellectual property, user conduct, disclaimers, and limitations of liability. Any unauthorized use of this website may give rise to a claim for damages and/or be a criminal offense.

Cookie Policy

This website uses cookies to enhance your Browse experience and analyze site traffic. By continuing to use our website, you consent to our use of cookies in accordance with this policy.

Cookies help us understand how you interact with our content, personalize your experience, and deliver relevant advertisements. You can manage your cookie preferences through your browser settings.

Ethics Statement

At MyraNeuro, ethical considerations are fundamental to our research and development. We are committed to developing AI and neurotechnology responsibly, ensuring fairness, transparency, and accountability.

Our ethical principles guide every stage of our work, from data collection and algorithm design to clinical deployment. We prioritize patient autonomy, beneficence, non-maleficence, and justice in all our innovations. Our AI models undergo rigorous **bias detection and mitigation processes** to ensure equitable outcomes across diverse demographic groups, with **regular independent audits**. We engage with ethical boards and public stakeholders to foster responsible innovation.

Regulatory Compliance

MyraNeuro adheres to the highest international standards for medical device development and data handling. We are compliant with major regulatory frameworks globally.

• **EU MDR (Medical Device Regulation):** Our devices meet the stringent requirements for safety and performance in the European Union.
• **FDA Regulations (US):** We are actively pursuing FDA clearances for our key technologies in the United States.
• **HIPAA (Health Insurance Portability and Accountability Act):** Strict adherence to patient data privacy and security in the U.S.
• **GDPR (General Data Protection Regulation):** Full compliance with data protection laws in the European Union.
• **ISO 13485:** Certified for Quality Management Systems for Medical Devices.

Our commitment to compliance ensures the safety, effectiveness, and reliability of our neurotechnology solutions worldwide.